突变PIK3CA是一种可向的驱动因子变异,在囊细胞性瘤中具有针对性
Benjamin H Durham1,2, Oshrat Hershkovitz-Rokah3,4, Omar Abdel-Wahab1
1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
Blood advances
|October 24, 2023
概括
激活PIK3CA突变驱动兰格汉斯细胞囊细胞化 (LCH). 用alpelisib准PI3K在患有PIK3CA突变LCH的患者中显示出有效性,突出显示了对质细胞瘤的个性化治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 朗格汉斯细胞囊细胞瘤 (LCH) 是一种由MAPK路径变化,特别是BRAFV600E突变驱动的炎症性髓状瘤.
- 在囊胞性瘤中观察到PIK3CA,ALK,RET和CSF1R等其他激酶的激活突变,但PIK3CA在造血细胞中的作用尚不清楚.
研究的目的:
- 调查PIK3CA突变在驱动质细胞瘤中的作用.
- 评估PI3K抑制使用alpelisib在PIK3CA突变的LCH.中的有效性.
主要方法:
- 在单细胞/状细胞原始细胞中产生了表达PIK3CAH1047R的条件诺金小鼠模型.
- 使用alpelisib治疗了一名患有多系统性LCH的患者,该患者患有PIK3CA突变.
主要成果:
- PIK3CAH1047R小鼠模型表明,这些突变可以在体内驱动质细胞瘤.
- 在患有PIK3CA突变LCH的患者中,阿尔佩利西布治疗导致了完全的临床和代谢缓解,具有可容忍的安全性.
结论:
- 确定PIK3CA是LCH.的可向,非正规的驱动器.
- 这些发现强调了突变分析对于囊细胞瘤瘤个性化治疗策略的重要性.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


